Moore Capital Management »

Cullinan Oncology shares owned by Moore Capital Management

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 106k 14.21

More positions owned by Moore Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ally Financial (ALLY)
Bank of America Corporation (BAC)
Ubs Group SHS (UBS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Apollo Global Mgmt (APO)
Coinbase Global Note 0.500% 6/0 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Etsy Note 0.125%10/0 (Principal)
Global Payments (GPN)
Fidelity National Information Services (FIS)

View all positions for Moore Capital Management

Top funds holding Cullinan Oncology

Lynx1 Capital Management
MPM Oncology Impact Management
BVF
BlackRock
Vanguard Group
Kynam Capital Management
Vanguard Capital Management
Blue Owl Capital Holdings
State Street Corporation
Affinity Asset Advisors
Rtw Investments
VR Adviser
Geode Capital Management
Siren
Nextech Invest

View all funds holding Cullinan Oncology